Sei Investments CO Arrowhead Pharmaceuticals, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$21.87 - $28.24 $18,939 - $24,455	-866 Reduced 8.04%	9,908 $257,000
Q1 2024 May 07, 2024	SELL	$27.21 - $39.48 $7,618 - $11,054	-280 Reduced 2.53%	10,774 $308,000
Q4 2023 Feb 14, 2024	SELL	$21.2 - $31.03 $2,968 - $4,344	-140 Reduced 1.25%	11,054 $338,000
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $129,087 - $177,766	-4,927 Reduced 30.56%	11,194 $300,000
Q2 2023 Aug 11, 2023	BUY	$25.16 - $41.38 $405,604 - $667,086	16,121 New	16,121 $574,000
Q4 2022 Feb 10, 2023	SELL	$28.0 - $40.56 $10,444 - $15,128	-373 Reduced 3.16%	11,447 $464,000
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $72,000 - $117,393	2,430 Added 25.88%	11,820 $391,000
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $4,001 - $7,287	-144 Reduced 1.51%	9,390 $331,000
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $148,852 - $262,877	-3,757 Reduced 28.27%	9,534 $438,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $15,684 - $22,277	-270 Reduced 1.99%	13,291 $881,000
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $13,369 - $19,455	-229 Reduced 1.66%	13,561 $847,000
Q2 2021 Aug 06, 2021	SELL	$62.15 - $90.32 $882,157 - $1.28 Million	-14,194 Reduced 50.72%	13,790 $1.14 Million
Q1 2021 May 12, 2021	SELL	$61.35 - $90.47 $38,957 - $57,448	-635 Reduced 2.22%	27,984 $2 Million
Q4 2020 Feb 08, 2021	BUY	$43.82 - $85.37 $592,227 - $1.15 Million	13,515 Added 89.48%	28,619 $2.2 Million
Q3 2020 Nov 06, 2020	BUY	$33.21 - $51.27 $145,127 - $224,049	4,370 Added 40.71%	15,104 $650,000
Q2 2020 Aug 17, 2020	BUY	$26.12 - $43.27 $164,608 - $272,687	6,302 Added 142.19%	10,734 $464,000
Q2 2020 Aug 11, 2020	BUY	$26.12 - $43.27 $115,763 - $191,772	4,432 New	4,432 $281,000
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $373,164 - $1.15 Million	-18,150 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$28.14 - $73.01 $165,632 - $429,736	-5,886 Reduced 24.49%	18,150 $1.15 Million
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $631,185 - $837,894	24,036 New	24,036 $677,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account